Safety and clinical activity of mutant IDH1 inhibitor IVOSIDENIB (IVO; AG-120) in combination with AZACITIDINE (AZA) for newly diagnosed acute myeloid leukemia (ND AML) Meeting Abstract
| Authors: | DiNardo, C.; Stein, A.; Stein, E.; Fathi, A.; Frankfurt, O.; Schuh, A.; Döhner, H.; Martinelli, G.; Patel, P.; Raffoux, E.; Tan, P.; Zeidan, A.; de Botton, S.; Kantarjian, H.; Stone, R.; Lam, D.; Wang, X.; Gong, J.; Kapsalis, S.; Hickman, D.; Zhang, V.; Winkler, T.; Wu, B.; Vyas, P. |
| Abstract Title: | Safety and clinical activity of mutant IDH1 inhibitor IVOSIDENIB (IVO; AG-120) in combination with AZACITIDINE (AZA) for newly diagnosed acute myeloid leukemia (ND AML) |
| Meeting Title: | Acute Leukemias XVII: Biology and Treatment Strategies |
| Journal Title: | Annals of Hematology |
| Volume: | 98 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Feb 24-27 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0939-5555 |
| Publisher: | Springer |
| Date Published: | 2019-02-01 |
| Start Page: | S40 |
| End Page: | S41 |
| Language: | English |
| ACCESSION: | WOS:000459100600042 |
| PROVIDER: | wos |
| PUBMED: | 30746560 |
| DOI: | 10.1007/s00277-019-03619-9 |
| Notes: | Meeting Abstract: 40a -- Title and authors are also listed on page S10 -- Source: Wos |
